Savanna Biotherapeutics

Aliso Viejo, CA · Founded 2020 · Privately Held (backing)

The company is currently operating in Stealth mode. Savanna Biotherapeutics is based in Aliso Viejo, CA and was founded in 2020. It was valued at $49 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $37.3 million across 1 recorded round; the latest was a $13 million early-stage round in Jun 2025.

PMV mark · valuation
$49.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$37.3M
Last round
Early Stage VC
Jun 2025
What is Savanna Biotherapeutics worth?
$49.0MPrivateMarketView mark · Oct 2026

Valued at $49.0M at its later-stage round, Jun 2025. Nothing has traded since.

Free account
More of Savanna Biotherapeutics with a free account
  • ·Watch Savanna Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Savanna Biotherapeutics funding history

1 rounds
DateRoundRaisedPost-money
Jun 2025Early Stage VC$13.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Savanna Biotherapeutics valuation

Savanna Biotherapeutics was valued at $49 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Savanna Biotherapeutics raised?

Savanna Biotherapeutics has raised $37.3 million in total; 1 of its rounds is on record. The largest on record was a $13 million early-stage round in Jun 2025.

Savanna Biotherapeutics has filed 1 Form D with the SEC, most recently in Jun 2025 ($13 million sold to 30 investors).

How Savanna Biotherapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Savanna Biotherapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Savanna Biotherapeutics

What is Savanna Biotherapeutics worth?
Savanna Biotherapeutics is valued at $49.0M as of Oct 2026. Valued at $49.0M at its later-stage round, Jun 2025. Nothing has traded since.
How much has Savanna Biotherapeutics raised?
Savanna Biotherapeutics has raised $37.3M in total funding across 1 recorded rounds.
When did Savanna Biotherapeutics last raise?
Savanna Biotherapeutics last raised in Jun 2025 (Early Stage VC), raising $13.0M.